13 reports

& nbsp; Emerging diagnostic technologies and their potential market applications.

  • Cancer
  • Cancer Diagnostic
  • Diagnostics
  • Spain
  • Demand

Neuroblastoma (NB)- Epidemiology Forecast to 2027 ##.

  • Cancer
  • France
  • Germany
  • Italy
  • Spain

Emerging diagnostic technologies and their potential market applications.

  • Cancer
  • Pathology
  • Spain
  • Demand

& nbsp; Emerging diagnostic technologies and their potential market applications.

  • Cancer
  • Pathology
  • Spain
  • Demand
  • 3.4 FORECAST METHODOLOGY

[Accessed November ##, 2015].

  • Cancer
  • Lymphoma
  • Pathology
  • Spain
  • Forecast
  • 3.4.7 Mutations (17p deletion, 11q Deletion, and TP53) Among the Diagnosed Incident Cases of CLL

LEUKEMIA; ##(##):##-##.

  • Cancer
  • Epidemiology
  • Hospital
  • Leukemia
  • Spain

STILL, PSA TESTING REMAINS A WIDELY AVAILABLE DIAGNOSTIC OPTION.

  • Cancer
  • Pathology
  • Prostate Cancer
  • Spain
  • Forecast
  • FEB 16, 2018: SPANISH CENTER SANTIAGO DE COMPOSTELA JOINS THE LARGEST EVER PROSPECTIVE STUDY INTO FAMILIAL RISK OF DEVELOPING PANCREATIC CANCER

IMMRAY™ IS A TECHNOLOGY PLATFORM FOR THE DEVELOPMENT OF DIAGNOSTIC TESTS AND THE COMPANY' S PRIMARY TEST.

  • Cancer
  • Hospital
  • Pancreatic Cancer
  • Spain
  • Product Initiative
  • 05/06/2016: EARLY DIAGNOSIS, A MULTIDISCIPLINARY APPROACH AND ACCESS TO NEW THERAPIES, KEY IN THE TREATMENT OF OVARIAN CANCER

The exchange ratio between the shares of the two companies was ##:##, one Pharma Mar share for each Zeltia share.

  • Cancer
  • Pharmaceutical
  • Spain
  • Company
  • Pharma Mar, S.A.
  • Prognostic Test - Colorectal Cancer - Product Status
  • Sep 14, 2011: Oryzon Genomics To Launch GynEC Dx Non Invasive Test For Detection Of Endometrial Cancer

From 2008 to 2010, Dr Greig was also President of SR One, GSK' s Corporate Venture Group.

  • Cancer
  • Genomics
  • Spain
  • Company
  • Oryzon Genomics S.A.
  • Personalized Medicine Test - Acute Lymphocytic Leukemia - Product Status
  • Indication

Notes Ongoing, Recruiting Ongoing, not Recruiting Ongoing, Recruiting by invitation Ongoing, not yet recruiting Recent Development section covers news posted during last one year GlobalData considers regulatory approved (Approved and Issued) products as pipeline in case products are yet to

  • Biotech
  • Cancer
  • Spain
  • Company
  • Product Initiative

(Roche) is a research-focused healthcare company that provides biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems.

  • Cancer
  • Spain
  • World
  • Product Initiative
  • Oryzon Genomics S.A.

Oxford Immunotec Global Plc (OIG) is a global, commercial-stage diagnostics company.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Spain